Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

Items 41-50 of 97

Page
per page
  1. HG-10-102-01
    B1262 HG-10-102-01
     1 Citation
    Target: LRRK2
    Summary: LRRK2 inhibitor
      insoluble in H2O; ≥18.9 mg/mL
  2. Fostamatinib (R788)
    B2284 Fostamatinib (R788)
    Target: Syk
    Summary: Spleen tyrosine kinase (Syk) inhibitor
      insoluble in H2O; ≥100.4 mg/mL
  3. Imatinib Mesylate (STI571)
    A1805 Imatinib Mesylate (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Abl/c-kit/PDGFR inhibitor
      ≥29.5 mg/mL
  4. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  5. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/InsR inhibitor,potent and selective
      ≥23.05 mg/mL
  6. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  7. FIIN-2
    A8696 FIIN-2
    Target: FGFR
    Summary: Irreversible inhibitor of FGFR
      ≥31.75 mg/mL
  8. NVP-AEW541
    A2278 NVP-AEW541
    Target: Insulin Receptor
    Summary: IGF-IR inhibitor, novel, potent and selective
      ≥22 mg/mL
  9. Motesanib
    A3632 Motesanib
    Target: VEGFR
    Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
      ≥42 mg/mL
  10. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL

Items 41-50 of 97

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 7item
  2. Axl 4item
  3. ALK 3item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 9item
  7. c-RET 3item
  8. CSF-1R 2item
  9. EGFR 18item
  10. FAK 3item
  11. FGFR 4item
  12. FLT3 4item
  13. HER2 8item
  14. IGF1R 3item
  15. IRAK 2item
  16. ITK 1 item
  17. LRRK2 4item
  18. PDGFR 8item
  19. Pyk2 1 item
  20. Spleen Tyrosine Kinase (Syk) 3item
  21. Src 6item
  22. Tie-2 2item
  23. Trk 2item
  24. VEGFR 18item
Specificity
  1. Selective 59item
Reversibility
  1. Reversible 5item
  2. Irreversible 5item
Target
  1. Histone Deacetylases (HDACs) 1 item
  2. Raf 4item
  3. Aurora Kinases 2item
  4. CSF-1R 4item
  5. MER 1 item
  6. FLT3 9item
  7. Eph Receptors 1 item
  8. VEGFR 24item
  9. PDGFR 15item
  10. c-Kit 8item
  11. RET 1 item
  12. IRAK 2item
  13. Bcr-Abl 7item
  14. FGFR 8item
  15. MET 5item
  16. Src 8item
  17. Trk Receptors 2item
  18. STAT 1 item
  19. EGFR 17item
  20. FAK 3item
  21. JAK 2item
  22. Syk 3item
  23. ErbB 4item
  24. c-MET 6item
  25. PKC 1 item
  26. Lyn 1 item
  27. HER2 1 item
  28. Pyk2 2item
  29. LRRK2 4item
  30. Insulin and Insulin-like Receptors 3item
  31. ALK 3item
  32. Angiotensin-Converting Enzymes (ACEs) 1 item
  33. Tie-2 3item
  34. Ron 1 item
  35. 5-Lipoxygenases 1 item
  36. Insulin Receptors 1 item
  37. IRG-1R 1 item
  38. ZAP-70 1 item
  39. Flk-1 1 item
  40. c-RET 2item
  41. TAM kinase 1 item
  42. KDR 1 item
  43. Fyn kinase 1 item
  44. Abl kinases 1 item
  45. AXL 1 item
  46. c-Fms tyrosine kinase 1 item
  47. insulin 1 item
  48. Mer tyrosine kinase 1 item
  49. ErbB-2 1 item
  50. ITK 1 item
  51. DCLK2 1 item
  52. PTK 1 item
  53. Flk1 1 item
  54. YES 1 item
  55. Fyn 1 item
  56. enoyl-acyl-carrier protein reductase 1 item
  57. tropomyosin receptor kinase 1 item
  58. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 66item
  8. Cervical Cancer 1 item
  9. Cholangiocarcinoma 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 8item
  14. Glioblastoma 6item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 3item
  17. Leukemia 2item
  18. Liver Cancer 2item
  19. Lung Cancer 3item
  20. Lung Carcinoma 2item
  21. Lymphoma 4item
  22. Melanoma 1 item
  23. Multiple Myeloma 2item
  24. Non-small Cell Lung Cancer 3item
  25. Ovarian Cancer 5item
  26. Pancreatic Cancer 9item
  27. Prostate Cancer 5item
  28. Renal Cancer 1 item
  29. Renal Cell Carcinoma 1 item
  30. Rheumatoid Arthritis 2item
  31. Thyroid Cancer 2item